Navigation Links
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
Date:11/12/2007

ADDISON, Texas, Nov. 12 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it has scheduled a conference call to discuss the third quarter 2007 financial results and provide a general business update on Wednesday, November 14, 2007 at 10:00 a.m. Eastern Time with Kerry P. Gray, President and CEO.

To participate in the conference call, please dial (800) 357-0498 for international callers dial (850) 429-1388 (access code 9283#) five to ten minutes prior to the initiation of the teleconference. If you are unable to listen to the live broadcast a replay of the call will be available starting on November 14, 2007 two hours following the end of the call until November 21, 2007 at 11:59 p.m. Eastern Time. For the U.S. replay, please dial (800) 695-0697 for international callers dial (402) 220-1472 (access code 9283#).

Interested investors and others may also listen to the conference call replay through our Internet webcast, which may be accessed by visiting our website at http://www.uluruinc.com and clicking on the "Investor Relations" icon.

About ULURU Inc.:

ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating) relating to future financial performance of ULURU Inc. (the "Company"). When used in this press release, the words "may,
'/>"/>

SOURCE ULURU Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
2. ULURU Inc. Announces Odd-Lot Buy Back Offer
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ses Association charged with illegally attaining p...cuses for unsolicited mailers to,workers, CORAL... California,Nurses Association (CNA) violated Iowa...ials to 2,000 nurses represented by the Service Em...ding to a lawsuit filed on behalf,of nurses today....
(Date:5/12/2008)...e effects, loss of effectiveness over time , ...s that are widely used to treat restless legs synd...ide effects and a gradual loss of effectiveness th...w analysis finds. , "One of the things that we ...e more robust effects early in therapy," said stud...
(Date:5/12/2008)...y 12 /PRNewswire-USNewswire/ -- Most baby boomers ...l disability, according to a,new survey conducted ...h,Insurance Plans (AHIP). Baby boomers would have ... into their retirement savings if a disability,occ...prnh/20040830/AHIPLOGO ), "Baby boomers have t...
(Date:5/12/2008)...sments worldwide verify safety and quality of tech... material., DENVER, May 12 /PRNewswire/ -- C5 Med...s for the medical device industry, has submitted a...nd Drug Administration (FDA) for,its new technical...cks.,ZirDent(TM) is a zirconium material ideally s...
Breaking Medicine News(10 mins):Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 2Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 3Health News:Drugs for Restless Legs Syndrome Have Downsides 2Health News:Drugs for Restless Legs Syndrome Have Downsides 3Health News:Most Baby Boomers are Financially Unprepared for a Potential Disability 2Health News:C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks 2
...s Hopkins have launched a nationwide study in USA ...ely performed in smaller hospitals. The study wil...potentially life-saving angioplasty //can be safel...itals, easing access to the therapy for patients. ...
...ed in the recent issue of The American Journal of ...d Hospital, Michigan, had concluded that obesity i...in people, more to those who are below the age of ...een thought to be a risk factor for fatal pulmonar...
...ers to reproduction by the development of an unfer...thout fertilization by spermatozoa. Sounds interes...s have been successful in creating so-called parth...from a single egg, without the need for sperm. The...
... embracing death together for a married couple in ...es instead of dying a little of humiliation everyd...ear-old man first poisoned to death his 25-year-ol...e Durgapur industrial town of south Bengal's Burdw...
Other Medicine News:
(Date:5/12/2008)...ike a radio dial, not an on/off,light switch; a di...evelop,late in life, MEMPHIS, Tenn., May 12 /PR...arch Hospital study shows that T cells, the body,s...f switches to govern the cellular,machinery that r...hey,possess sophisticated molecular controls that ...
(Date:5/12/2008)...irstCall/ -- Arbios Systems, Inc.,(OTC Bulletin Bo...ceived,approval from the U.S. Food and Drug Admini...ption ("IDE") to begin the pivotal clinical,trial ... body) liver assist,device for blood purification ...er disease., "We are pleased to have received FDA...
(Date:5/12/2008)... Improvement in T-Cell Responses Further S... DIEGO, May 12 /- Nventa Bi...unced positive immunological data from the,third c... lead product,candidate, HspE7, in patients with c...rsor to cervical cancer. HPV 16 E7-specific T-cell...
(Date:5/9/2008)...swire/ -- Many strong acting pain,medications have... and,vomiting with short-term use, and constipatio... patients to discontinue treatment, adding additio...s. The novel investigational,medication tapentadol...,relief for patients with fewer gastrointestinal s...
Breaking Medicine Technology:St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Patients perceived cancer care unaffected by lower Medicare reimbursements 3071 1Patients perceived cancer care unaffected by lower Medicare reimbursements 3071 2More Damage Than Good 3F Shock Survey Reveals Sport can Actually be bad for Your Joints 3067 1More Damage Than Good 3F Shock Survey Reveals Sport can Actually be bad for Your Joints 3067 2More Damage Than Good 3F Shock Survey Reveals Sport can Actually be bad for Your Joints 3067 3Great disappointment in veto of SCHIP legislation expressed by American College of Physicians 3063 1Great disappointment in veto of SCHIP legislation expressed by American College of Physicians 3063 2Heart Healthy Workouts Help Knees Too 3059 1Heart Healthy Workouts Help Knees Too 3059 2
...ORNE, N.Y.--(BUSINESS WIRE)--Apr 25, 2007 - Acorda...ced that Dr.,Lauren Krupp, Professor of Neurology ...Acorda,s Phase 3 clinical trial of,Fampridine-SR i...,reception on May 2, 2007. This reception will fol...ademy of Neurology (AAN) annual,meeting., Dr. Krup...
...NHAGEN, Denmark; April 25, 2007 - Genmab A/S (CSE:...II study with,ofatumumab (HuMax-CD20™) in pa...cepted for oral presentation at the 2007,Annual Eu...presentation, which will include new results from ...y with ofatumumab, along with data,from the previo...
Other Medicine Technology:Acorda Therapeutics to Host Analyst and Investor Reception 2
Safe-Wrap Combo Blood Collection Tubes are used for the collection of capillary blood samples for use with i-STAT blood gas, electrolyte, and chemistry cartridges requiring either 95 L or 65 L of sam
...r's FEMTO LDV, the first compact, mobile femtoseco... versatile, powerful platform for a wide spectrum ...em addresses the demand of refractive surgeons for...t with an efficient LASIK work-flow. The solution ...
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure.
Classic, stylish, and preppy, this collection features men's, women's and unisex styles.
Medicine Products: